Hu Lane Associate (6279.TWO) Earnings Analysis
Hu Lane Associate (6279.TWO) next reports earnings on 2026-08-06, consensus EPS 2.32 TWD. Last quarter (2026-03-10) it beat with EPS 4.33 TWD vs 3.84 TWD est (+12.8%). It has beaten estimates in 2/3 recent quarters (67%). Trailing P/E 12.27.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 6279.TWO next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | 2.32 TWD |
| Revenue estimate | 2.70B |
6279.TWO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-10 | 4.33 TWD | 3.84 TWD | +12.8% | Beat |
| 2025-03-13 | 3.38 TWD | 3.74 TWD | -9.6% | Miss |
| 2024-11-08 | 2.9 TWD | 2.62 TWD | +10.7% | Beat |
Beat rate: 2/3 (67%) over reported quarters with consensus data.
6279.TWO valuation and analyst view
| Trailing P/E | 12.27 |
|---|---|
| Trailing EPS | 9.271 TWD |
| Price / book | 1.48 |
| Dividend yield | 5.22% |
| Market cap | 13.92B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Hu Lane Associate (6279.TWO)'s next earnings date?
Hu Lane Associate is next scheduled to report on 2026-08-06, with a consensus EPS estimate of 2.32 TWD and revenue estimate of 2.70B.
Did 6279.TWO beat earnings last quarter?
In its 2026-03-10 report, 6279.TWO posted EPS of 4.33 TWD versus a 3.84 TWD estimate — a beat of 12.8%.
What is 6279.TWO's earnings track record?
Over the last 3 reported quarters with consensus data, 6279.TWO beat estimates 2 times (67%).
What is 6279.TWO's current P/E ratio and EPS?
6279.TWO trades at a trailing P/E of 12.27 on trailing EPS of 9.27087155392112 TWD.
What do analysts rate 6279.TWO?
6279.TWO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.